SEC Filings | Bionano Genomics, Inc.

Filing date	Description	Form	View
May 6, 2020	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	0001140361-20-010867.pdf 0001140361-20-010867.rtf 0001140361-20-010867.xls View HTML
May 5, 2020	Report of unscheduled material events or corporate event	8-K	0001140361-20-010645.pdf 0001140361-20-010645.rtf 0001140361-20-010645.xls View HTML
Apr 24, 2020	Report of unscheduled material events or corporate event	8-K	0001140361-20-009707.pdf 0001140361-20-009707.rtf 0001140361-20-009707.xls View HTML
Apr 20, 2020	Report of unscheduled material events or corporate event	8-K	0001140361-20-009285.pdf 0001140361-20-009285.rtf 0001140361-20-009285.xls View HTML
Apr 7, 2020	Statement of changes in beneficial ownership of securities	4	0001209191-20-023733.pdf 0001209191-20-023733.rtf 0001209191-20-023733.xls View HTML
Apr 6, 2020	Report of unscheduled material events or corporate event	8-K	0001140361-20-008106.pdf 0001140361-20-008106.rtf 0001140361-20-008106.xls View HTML
Apr 3, 2020	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	424B4	0001140361-20-007878.pdf 0001140361-20-007878.rtf 0001140361-20-007878.xls View HTML
Apr 2, 2020	POS EX	POS EX	0001140361-20-007746.pdf 0001140361-20-007746.rtf View HTML
Apr 1, 2020	Registration of up to an additional 20% of securities for any offering registered on an S-1	S-1MEF	0001140361-20-007747.pdf 0001140361-20-007747.rtf 0001140361-20-007747.xls View HTML
Apr 1, 2020	EFFECT	EFFECT	9999999995-20-000664.xls View HTML

Data provided by Kaleidoscope.